Followers

Tuesday, May 10, 2022

Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...

from NDTV News - Special https://ift.tt/HAad5FK

No comments:

Post a Comment

Will Tata Sons get listing waiver? RBI tweak will make it 'upper NBFC'

The Reserve Bank of India is proposing a simpler asset-size threshold of Rs 1 lakh crore to identify large NBFCs for stricter regulation, re...